And Chalcogen Bonded Directly To The Other Ring Carbon Of The Five-membered Hetero Ring Which Is Adjacent To The Ring Nitrogen (e.g., Succinimide, Etc.) Patents (Class 548/545)
  • Publication number: 20020091068
    Abstract: Succinimide-acid compounds prepared by reaction of hydrocarbyl-substituted succinic acylating agents with alpha-omega amino acids are disclosed, as well as derivatives thereof useful as lubricity additives, lubricant dispersants, friction modifiers, liquid hydrocarbonaceous fuel detergents, antioxidants and alkali and/or alkaline-earth metal detergents.
    Type: Application
    Filed: November 8, 2001
    Publication date: July 11, 2002
    Inventor: John T. Loper
  • Patent number: 6392104
    Abstract: In the presence of an imide compound (e.g., N-hydroxyphthalimide) shown by the formula (2): wherein R1 and R2 independently represents a hydrogen atom, a halogen atom, an alkyl group, an aryl group, a cycloalkyl group; or R1 and R2 may bond together to form a double bond or an aromatic or non-aromatic ring; Y is O or OH and n=1 to 3; or the imide compound and a co-catalyst (e.g., a transition metal compound), an adamantane derivative having a functional group such as a nitro group, an amino group, a hydroxyl group, a carboxyl group, a hydroxymethyl group and an isocyanato group is oxidized with oxygen. According to the above method, an adamantane derivative having a hydroxyl group together with a functional group such as a nitro group, an amino group, a hydroxyl group, a carboxyl group, a hydroxymethyl group and an isocyanato group is efficiently obtained.
    Type: Grant
    Filed: November 10, 1998
    Date of Patent: May 21, 2002
    Assignee: Daicel Chemical Industries, Ltd.
    Inventors: Yasutaka Ishii, Tatsuya Nakano, Naruhisa Hirai
  • Patent number: 6388094
    Abstract: A synthesis is described for intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors. The method includes forming a diastereoselective epoxide from a chiral alpha amino aldehyde.
    Type: Grant
    Filed: November 1, 1999
    Date of Patent: May 14, 2002
    Assignee: G.D. Searle & Co.
    Inventors: John S Ng, Claire A. Przybyla, Richard A Mueller, Michael L Vazquez, Daniel P Getman
  • Patent number: 6365615
    Abstract: Novel compounds of the formula I which are useful for treating or preventing inflammatory and immune cell-mediated diseases. Exemplary compounds are: 2-(3,5-Dichlorophenyl)-7-(R*)-phenyl-7a-(R*)-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione; 2-(3,5-Dichlorophenyl)-7a-(R*)-methyl-7-(R*)-phenyl-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione; and, 7-(R*)-(4-Bromophenyl)-2-(3,5-dichlorophenyl)-7a-(R*)-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: April 2, 2002
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Terence Alfred Kelly, Jiang-Ping Wu, Daniel Kuzmich
  • Patent number: 6352566
    Abstract: Ethers of polyalkyl or polyalkenyl N-hydroxyalkyl succinimides having the formula: or a fuel soluble salt thereof; wherein R is a polyalkyl or polyalkenyl group having an average molecular weight in the range of about 450 to about 5,000; n is an integer from 2 to 5; and Z is a moiety selected from the group consisting of  wherein R1 is a hydroxy, nitro, cyano or —(CH2)x—NR3R4, wherein R3 and R4 are independently hydrogen or lower alkyl of 1 to 6 carbon atoms and x is 0 or 1; and R2 is hydrogen, hydroxy, nitro, cyano or —(CH2)y—NR5R6, wherein R5 and R6 are independently hydrogen or lower alkyl of 1 to 6 carbon atoms and y is 0 or 1. The compounds of formula I are useful as fuel additives for the prevention and control of engine deposits.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: March 5, 2002
    Assignee: Chevron Chemical Company LLC
    Inventor: Richard E. Cherpeck
  • Patent number: 6348600
    Abstract: A method for making an optically active 3-aminopyrrolidine-2,5-dione derivative represented by the formula (3) includes cyclizing an optically active asparagine ester derivative represented by the formula (1) or (2), or an acid salt thereof. A method for making an optically active 3-aminopyrrolidine derivative represented by the formula (9) includes reducing the optically active 3-aminopyrrolidine-2,5-dione derivative represented by the formula (3). A method for making an optically active 3-aminopyrrolidine derivative includes hydrogenolyzing the optically active 3-aminopyrrolidine derivative represented by the formula (9).
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: February 19, 2002
    Assignee: Toray Industries, Inc.
    Inventors: Takae Ono, Haruyo Sato
  • Publication number: 20020010204
    Abstract: The invention relates to novel phenyl-substituted cyclic ketoenols of the formula (I) 1
    Type: Application
    Filed: March 15, 2001
    Publication date: January 24, 2002
    Inventors: Folker Lieb, Reiner Fischer, Thomas Bretschneider, Michael Ruther, Alan Graff, Udo Schneider, Christoph Erdelen, Ulrike Wachendorff-Neuman, Wolfram Andersch, Andreas Turberg
  • Patent number: 6303795
    Abstract: A surfactant which is the reaction product of a hydrocarbyl-substituted succinic anhydride or a reactive equivalent thereof with at least one water-dispersible amine-terminated poly(oxyalkylene), is effective for use in soil remediation.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: October 16, 2001
    Assignee: The Lubrizol Corporation
    Inventors: Richard W. Jahnke, Bryan A. Grisso
  • Publication number: 20010018441
    Abstract: The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory cell adhesion molecule expression inhibitor, anti-inflammatory agent, antirheumatic agent, immunosuppressant, cancer metastasis inhibitor, remedy for arteriosclerosis and antiviral agent which contain the benzene derivative of the following general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: March 12, 2001
    Publication date: August 30, 2001
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Kohichi Fujita, Takashi Tsuji, Ariko Kodaira, Kenji Takehana, Tsuyoshi Kobayashi, Takashi Yamamoto
  • Patent number: 6277997
    Abstract: The present invention relates to a process for the preparation of compounds of formula I wherein R1 and R2 are as defined in the specification as well as to the novel intermediates obtained by said process.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: August 21, 2001
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michelangelo Scalone, Ulrich Zutter
  • Patent number: 6262222
    Abstract: Copolymers containing N-vinyllactam derivatives protected at 3-position are provided and represented by the following formula. The copolymers are used as a photoresist material suitable for deep uv process so that high sensitivity and resolution can be obtained. In addition, ultrafine circuits can be formed and an exceptional improvement in PED stability can be accomplished by use of the photoresist.
    Type: Grant
    Filed: October 8, 1998
    Date of Patent: July 17, 2001
    Assignee: Hyundai Electronics Industries Co., Ltd.
    Inventors: Jin Baek Kim, Min Ho Jung, Jong Ho Cheong
  • Patent number: 6229020
    Abstract: A new reagent for preparation of a caged compound in accordance with the present invention is a compound having, as a basic structure, an N-succinimidyl cinnamate structure expressed by the following formula 1: Another reagent for preparation of a caged compound in accordance with the present invention is a compound having, as a basic structure, a p-nitrophenyl cinnamate structure expressed by the following formula 3:
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: May 8, 2001
    Assignee: Laboratory of Molecular Biophotonics
    Inventor: Hirofumi Shiono
  • Patent number: 6174989
    Abstract: The present invention relates to rubber compounds containing polymeric bis-succinimide polysulfides of the formula: wherein R is selected from the group consisting of phenylene and xylylene; R1 is selected from the group consisting hydrogen and alkyls having from 1 to 18 carbon atoms; x is an integer of from 2 to 8 and y is an integer of from 2 to 10.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: January 16, 2001
    Assignee: The Goodyear Tire & Rubber Company
    Inventors: Richard Michael D'Sidocky, Lawson Gibson Wideman
  • Patent number: 6160128
    Abstract: Novel acetylating and tritioacetylating reagents suitable for preparation of nonlabelled and radiolabelled organic compounds. N-acetoxynaphthalimide, N-tritioacetoxyphthalimide, N-tritioacetoxysuccinimide, N-tritioacetoxynaphthalimide and processes of their preparation. The invention also concerns synthesis of nonlabelled acetylated and tritioacetylated organic compounds from precursors containing a free --NH.sub.2, --SH or --OH group.
    Type: Grant
    Filed: October 23, 1998
    Date of Patent: December 12, 2000
    Assignee: The Regents of the University of California
    Inventors: Manoucher Saljoughian, Hiromi Morimoto, Philip G. Williams, Chit Than
  • Patent number: 6143902
    Abstract: A chemic compound having the formula: ##STR1## wherein P.sub.1 is a hydroxyl protecting group, R.sub.1 is an alkyl group, an olefinic group, an aromatic group, Ph, PhCH.sub.2, an O-alkyl group, an O-olefinic group, an O-aromatic group, O--Ph, or O--CH.sub.2 Ph, and wherein Z is an N-imido group. In particular, P.sub.1 may be selected from the group consisting of benzyl, benzyloxymethyl and benzoyl, and Z may be a heterocyclic N-imido group, preferably having 5 to 7 atoms in the ring and alternatively substituted with at least one electron withdrawing group, preferably selected from the group consisting of a chloro group, a fluoro group and a nitro group. In particular, it is contemplated that Z may be succinimido, phthalimido, 5-norbornene-2,3-dicarboxyimido, maleimido and substituted derivatives thereof.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: November 7, 2000
    Assignee: NaPro BioTherapeutics, Inc.
    Inventors: Jan Zygmunt, James D. McChesney, Madhavi C. Chander
  • Patent number: 6127427
    Abstract: Compounds of general formula (I) ##STR1## wherein X ia a --CO.sub.2 H, --NH(OH)CHO or --CONHOH group; R.sub.1 is a cylcoalkyl, cycloalkenyl or non-aromatic heterocyclic ring containing up to 3 heteroatoms, any of which may be (i) substituted by one ore more substituents selected from C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, halo, cyano (--CN), --CO.sub.2 H, --CO.sub.2 R, --CONH.sub.2, --CONHR, --CON(R).sub.2, --OH, --OR, oxo-, --SH, --SR, --NHCOR, and --NHCO.sub.2 R wherein R is C.sub.1 -C.sub.6 alkyl or benzyl and/or (ii) fused to a cycloalky or heterocyclic ring; and R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as defined in specification are matrix metalloproteinase inhibitors.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: October 3, 2000
    Assignee: British Biotech Pharmaceuticals Limited
    Inventors: Fionna Mitchell Martin, Christopher Norman Lewis, Mark Whittaker
  • Patent number: 6114419
    Abstract: Fluorinated imides useful for imparting repellency of low surface tension fluids to thermoplastic polymers of formulae ##STR1## wherein R.sub.1 is F(CF.sub.2).sub.x --(CH.sub.2).sub.m, or F(CF.sub.2).sub.x SO.sub.2 N(R.sub.5) (CH.sub.2)p wherein x is from about 4 to about 20, m is from about 2 to about 6, p is from 1 to about 12, and R.sub.5 is an alkyl radical of from 1 to about 4 carbons;R.sub.2 is a linear, branched or cyclic alkylene or poly(oxyalkylene) hydrocarbon group having from about 2 to about 15 carbons;R.sub.3 is selected from the group consisting of F(CF.sub.2).sub.x --(CH.sub.2).sub.m, F(CF.sub.2).sub.x --(CH.sub.2).sub.m --OC(O)--(CH.sub.2).sub.n, and F(CF.sub.2).sub.x SO.sub.2 N(R.sub.5)(CH.sub.2).sub.p OC(O)(CH.sub.2).sub.n wherein x is from about 4 to about 20, m is from about 2 to about 6, n is about 2 to about 12, p is from 1 to about 12, and R.sub.5 is an alkyl radical of from 1 to about 4 carbons;R.sub.4 is an alkyl or alkenyl group of from about 4 to about 20 carbons, andR.sub.
    Type: Grant
    Filed: April 7, 1998
    Date of Patent: September 5, 2000
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Theodor Arthur Liss, Kimberly Gheysen Raiford, Edward James Greenwood
  • Patent number: 6093820
    Abstract: A method of N-alkoxyalkylating ureides according to the invention comprises reacting a ureide of structure I ##STR1## with an alkylating agent of structure III ##STR2## in the presence of a basic catalyst in an aprotic reaction medium. The ureide may be a 5,5-disubstituted barbituric acid, or it may be phenytoin, glutethimide, and ethosuximide. The alkylating agent is an ester of a sulfonic acid. The base may be a hydride or amine. A preferred process comprises N-alkoxyalkylating 5,5-diphenyl-barbituric acid with methoxymethyl methanesulfonate in the presence of di-isopropyl ethyl amine and isolating the resultant N,N'-bismethoxymethyl-5,5-diphenyl-barbituric acid. The invention also contemplates the novel compounds N-methoxymethyl-5,5-diphenylbarbituric acid, N-methoxymethyl ethosuximide, and N-methoxymethyl glutethimide, and a method comprising administering them to a patient.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: July 25, 2000
    Assignee: Taro Pharmaceutical Industries Ltd.
    Inventors: Daniela Gutman, Hershel Herzog
  • Patent number: 6080839
    Abstract: The invention relates to a novel labeling reactant, suitable for labeling of a biospecific binding reactant using solid-phase synthesis. The invention further concerns new labeling methods. The novel labeling reactant has the formula (I) ##STR1## wherein -A- is a bivalent aromatic structure capable of absorbing light or energy and transferring the excitation energy to a lanthanide ion after the product made by the said solid-phase synthesis has been released from the used solid support, deprotected and converted to a lanthanide chelate;-G- is a bridge replacing a hydrogen atom in A;R is a protected amino acid residue --CH(NHX)COOH, where X is a transient protecting group, or its active ester, where said ester is e.g. an N-hydroxysuccinimido, p-nitrophenol or pentafluorophenol ester; andR' is --COOR'" where R'" is an alkyl of 1 to 4 carbon atoms, phenyl or benzyl, which phenyl or benzyl can be substituted or unsubstituted.
    Type: Grant
    Filed: June 25, 1998
    Date of Patent: June 27, 2000
    Assignee: Wallac Oy
    Inventors: Harri Takalo, Jari Hovinen, Veli-Matti Mukkala, Paivi Liitti, Heikki Mikola
  • Patent number: 6051678
    Abstract: Copolymers containing N-vinyllactam derivatives protected at 3-position are provided and represented by the following formula. The copolymers are used as a photoresist material suitable for deep uv process so that high sensitivity and resolution can be obtained. In addition, ultrafine circuits can be formed and an exceptional improvement in PED stability can be accomplished by use of the photoresist.
    Type: Grant
    Filed: March 13, 1997
    Date of Patent: April 18, 2000
    Assignee: Hyundai Electronics Industries Co., Ltd.
    Inventors: Jin Baek Kim, Min Ho Jung, Jong Ho Cheong
  • Patent number: 6048840
    Abstract: This invention relates to novel insulin-potentiating hypoglycaemic compounds.
    Type: Grant
    Filed: April 1, 1994
    Date of Patent: April 11, 2000
    Assignee: Monash University
    Inventors: Milton Thomas William Hearn, Frank Man-Woon Ng, Victoria Marie Jane Robson, Michael Francis O'Donoghue, Ian David Rae
  • Patent number: 6037477
    Abstract: An ether is oxidized with oxygen under an oxidation catalyst comprising an imide compound (such as N-hydroxyphthalimide) or the imide compound and a co-catalyst to produce the corresponding chain or cyclic ester or anhydride. The co-catalyst may be a transition metal compound. The above process provides a process for oxidizing an ether by oxygen efficiently to produce the corresponding oxide (such as an ester, an hydride) with high conversion and selectivity.
    Type: Grant
    Filed: May 8, 1998
    Date of Patent: March 14, 2000
    Assignees: Daicel Chemical Industries, Ltd., Yasutaka Ishii
    Inventors: Yasutaka Ishii, Tatsuya Nakano
  • Patent number: 6025501
    Abstract: What is described herein are derivatized polymers of .alpha.-olefin-maleic anhydride alkyl half-ester or full acid, preferably the isobutylene compound, optionally with repeat units of maleamic acid and/or its corresponding maleimide therein. These polymers are useful as fixatives in personal care products, such as hair spray compositions, particularly as one-phase, low VOC formulations in pump and aerosol systems, and in anhydrous, alcoholic, aqueous-alcoholic and in high hydrocarbon tolerant solvent formulations. In use, these hair spray compositions dry down to form clear, continuous and defectless films.
    Type: Grant
    Filed: June 24, 1998
    Date of Patent: February 15, 2000
    Assignee: ISP Investments Inc.
    Inventors: Herbert W. Ulmer, Timothy Gillece, John A. Katirgis, Linda C. Foltis, April Blaine
  • Patent number: 6017943
    Abstract: The present invention provides a class of compounds having the formula:Y--R--CH.sub.2 --CH.sub.2 --[O--CH.sub.2 --CH.sub.2 ].sub.n --R'--Y'wherein n is an integer from about 5 to about 200; R is carbamate, urea, or amide; R' is carbamate, urea, amide, or oxygen; Y is 4-phenylmalemimido or 3-phenylmaleimido; and Y' is 4-phenylmalemimido, 3-phenylmaleimido, methyl or hydrogen. The present invention also provides various hemoglobin compositions modified with the class of compounds of the present invention, processes for preparing these compositions, as well as pharmaceutical compositions comprising these compositions.
    Type: Grant
    Filed: February 4, 1998
    Date of Patent: January 25, 2000
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: A. Seetharama Acharya, Belur N. Manjula, Paul K. Smith
  • Patent number: 6015904
    Abstract: This invention provides novel reagents for the preparation of radiopharmaceuticals useful as imaging agents for the diagnosis of cardiovascular disorders, infection, inflammation and cancer, diagnostic kits comprising said reagents and intermediate compounds useful for the preparation of said reagents. The reagents are comprised of stable hydrazone modified biologically active molecules that react with gamma emitting radioisotopes to form radiopharmaceuticals that selectively localize at sites of disease and thus allow an image to be obtained of the loci using gamma scintigraphy.
    Type: Grant
    Filed: October 23, 1997
    Date of Patent: January 18, 2000
    Inventors: Michael Sworin, Milind Rajopadhye, Thomas David Harris, David Scott Edwards, Edward Hollister Cheesman, Shuang Liu
  • Patent number: 6005069
    Abstract: Polysuccinimide of varying molecular weight has been prepared in a solvent system by heat polymerization of aspartic acid. The solvent system includes a sulfur oxygen acid and a sulfur oxygen acid salt. In a preferred embodiment, aspartic acid is polymerized in a liquid solvent reaction mixture at a temperature in the range of about 110.degree. C. to about 320.degree. C.
    Type: Grant
    Filed: December 18, 1996
    Date of Patent: December 21, 1999
    Assignee: Donlar Corporation
    Inventors: Grigory Ya. Mazo, Jacob Mazo
  • Patent number: 5965746
    Abstract: Provided are methods for the synthesis of N-cyclic maleamic acids and N-cyclic maleimide derivatives, as well as N-cyclic maleamic acids and N-cyclic maleimides synthesized thereby. The method for synthesis of an N-cyclic maleamic acid involves reacting an amino group-containing N-cyclic compound with maleic anhydride in acetic acid to obtain an N-cyclic maleamic acid. An N-cyclic maleimide can be formed by adding hexamethyldisilazane to an N-cyclic maleamic acid prepared according to the above-described method, thereby cyclizing a maleamic acid site of the N-cyclic maleamic acid. The described methods allow for the products to be obtained at high yields.
    Type: Grant
    Filed: June 2, 1998
    Date of Patent: October 12, 1999
    Assignee: Aisin Seiki Kabushiki Kaisha
    Inventors: Satoshi Fujita, Paidi Yella Reddy, Takeshi Toru
  • Patent number: 5959122
    Abstract: A process for making derivatized polymers of maleic anhydride containing maleamic acid and its corresponding cyclic imide repeat units, in alcohol solution, at a temperature of about 60-160.degree. C., during a reaction period of about 1-25 hours. The product is a polymer having a predetermined ratio of the above repeat units.
    Type: Grant
    Filed: June 24, 1998
    Date of Patent: September 28, 1999
    Assignee: ISP Investments Inc.
    Inventors: Herbert W. Ulmer, John A. Katirgis, Timothy Gillece
  • Patent number: 5958821
    Abstract: A substrate (e.g., a cycloalkane, a polycyclic hydrocarbon, an aromatic compound having a methyl group or methylene group adjacent to an aromatic ring) is oxidized with oxygen in the presence of an oxidation catalyst comprising an imide compound of the following formula (1) (e.g., N-hydroxyphthalimide), and a co-catalyst (except phosphovanadomolybdic acid) containing an element selected from the group consisting of Group 2A elements of the Periodic Table of Elements, transition metals (Group 3A to 7A elements, Group 8 elements, Group 1B elements and Group 2B elements of the Periodic Table of Elements) and Group 3B elements of the Periodic Table of Elements, for the formation of an oxide (e.g., a ketone, an alcohol, a carboxylic acid): ##STR1## wherein R.sup.1 and R.sup.2 represent a substituent such as a hydrogen atom or a halogen atom, or R.sup.1 and R.sup.2 may together form a double bond or an aromatic or nonaromatic 5- to 12-membered ring, X is O or OH, and n is 1 to 3.
    Type: Grant
    Filed: September 24, 1997
    Date of Patent: September 28, 1999
    Assignee: Daicel Chemical Industries, Ltd.
    Inventors: Yasutaka Ishii, Tatsuya Nakano
  • Patent number: 5958957
    Abstract: The present invention relates to novel organic compounds, to methods for their preparation, to compositions containing them, to their use for treatment of human and animal disorders, to their use for purification of proteins or glycoproteins, and to their use in diagnosis. The invention relates to modulation of the activity of molecules with phospho-tyrosine recognition units, including protein tyrosine phosphatases (PTPases) and proteins with Src-homology-2 domains, in in vitro systems, microorganisms, eukaryotic cells, whole animals and human beings. The novel organic compounds are compounds of formula (I)(L).sub.n --Ar.sub.1 --R.sub.1 --A (I)wherein(L).sub.n, n, Ar.sub.1, R.sub.1 and A are as defined in the application.
    Type: Grant
    Filed: April 16, 1997
    Date of Patent: September 28, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Sune Andersen, Niels Peter Hundahl Moller, Peter Madsen
  • Patent number: 5916825
    Abstract: A compound of the formula: ##STR1## wherein R.sub.1 is a polyisobutanyl group derived from a highly reactive polyisobutene having an average molecular weight in the range of from about 500 to 5,000;R.sub.2 is an alkylene group having from about 2 to 6 carbon atoms; andx is an integer from about 1 to 4.The polyisobutanyl succinimides of the present invention are useful as fuel additives for the prevention and control of engine deposits.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: June 29, 1999
    Assignee: Chevron Chemical Company LLC
    Inventor: Richard E. Cherpeck
  • Patent number: 5886194
    Abstract: This invention describes hydroxyamino-derivatized polymers of .alpha.-olefin-maleic anhydride in the form of their maleimide, maleamic acid and .alpha.-olefin-maleic anhydride half-acid/half ester or full acid repeat units process for making same. The polymers are made by reacting an .alpha.-olefin-maleic anhydride, half-acid/half-ester or full acid with a hydroxy containing .alpha.-unsubstituted primary amine in aqueous or aqueous alcoholic solution at a temperature of about 60.degree.-160.degree. C. during a reaction period of about 1-25 hours.
    Type: Grant
    Filed: June 24, 1998
    Date of Patent: March 23, 1999
    Assignee: ISP Investments Inc.
    Inventors: Herbert W. Ulmer, Timothy Gillece, John A. Katirgis
  • Patent number: 5880070
    Abstract: A polyalkylene succinimide composition prepared by reacting a mixture of an acid derivative, a polycarboxylic acid derivative; and a polyamine under reactive conditions. The acid derivative can be an alkenyl or alkylsuccinic acid derivative, a copolymer of a first unsaturated acidic reagent and a 1,1-disubstituted olefin, or mixtures of the alkenyl or alkylsuccinic acid derivative and the copolymer. The total reaction mixture contains from 4 to 40 wt. % of the polycarboxylic acid derivative, and contains from 0.1 to 1.5 equivalents of polyamine per equivalent of acidic groups of the acid derivative plus the acidic groups of the polycarboxylic acid derivative.
    Type: Grant
    Filed: August 20, 1996
    Date of Patent: March 9, 1999
    Assignee: Chevron Chemical Company
    Inventors: James J. Harrison, William R. Ruhe, Jr.
  • Patent number: 5877204
    Abstract: The present invention relates to compounds which are useful as sunscreens. The compounds persist on the skin for much longer than conventional sunscreens because they comprise a Michael acceptor linked directly or indirectly to a chromophore. The Michael acceptor is capable of undergoing a conjugate addition reaction with thiol groups present in cysteine residues of keratin and thus the compound is chemically bound to the skin and will not be removed by immersion in water.
    Type: Grant
    Filed: November 5, 1996
    Date of Patent: March 2, 1999
    Assignee: Vanguard Medica Limited
    Inventors: Bruce Everett Davison, Bryan Colin Nicholas Morgan Jones, Charon Robin Ganellin, Paul Beaumont Bishop, David Jack
  • Patent number: 5874459
    Abstract: Disclosed is a method of inhibiting anandamide amidase in an individual or animal and novel inhibitors of anandamide amidase. The disclosed method and novel compounds can be used to reduce pain in an individual or animal suffering from pain, reducing nausea in an individual undergoing chemotherapy, for example cancer chemotherapy, suppressing appetite in an individual, reducing intraocular pressure in the eye of an individual or animal suffering from glaucoma and suppressing the immune system in an individual with an organ transplant.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: February 23, 1999
    Assignee: University of Connecticut
    Inventors: Alexandros Makriyannis, Sonyan Lin, William Adam Hill
  • Patent number: 5872261
    Abstract: A process is described for rapid preparation of pure sulfo-N-hydroxysuccinimides. The process may comprise the steps of:a) esterifying a sulfo-succinic acid to form a diester first product, andb) reacting said diester first product with hydroxylamine to form a sulfo-N-hydroxy succinimide.
    Type: Grant
    Filed: September 18, 1997
    Date of Patent: February 16, 1999
    Assignee: Pierce Chemical Company
    Inventors: Martin Lee Bremmer, Marty Carey Wilkes
  • Patent number: 5869693
    Abstract: The invention disclosed relates to novel functionalized benzocyclobutenones of structural formula I ##STR1## wherein R is NH.sub.2, reactive NH.sub.2 derivatives including acids, acid chlorides, amides and diazonium salts, OH, CN, NO.sub.2, H, I, F Br, Cl, mercapto and deuterium. Also disclosed are polymer compositions comprising thermal reaction products of the benzocyclobutenones of formula I and either a polyol or a polyamine.
    Type: Grant
    Filed: April 24, 1997
    Date of Patent: February 9, 1999
    Assignee: Carleton University
    Inventor: Zhi Yuan Wang
  • Patent number: 5869695
    Abstract: A process for making derivatized polymers of maleic anhydride containing maleamic acid and its corresponding cyclic imide repeat units, in alcohol solution, at a temperature of about 60.degree.-160.degree. C., during a reaction period of about 1-25 hours. The product is a polymer having a predetermined ratio of the above repeat units.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: February 9, 1999
    Assignee: ISP Investments Inc.
    Inventors: Herbert W. Ulmer, John A. Katirgis
  • Patent number: 5858653
    Abstract: Method and reagent composition for covalent attachment of target molecules, such as nucleic acids, onto the surface of a substrate. The reagent composition includes groups capable of attracting the target molecule as well as groups capable of covalently binding to the target molecule, once attracted. Optionally, the composition can contain photoreactive groups for use in attaching the reagent composition to the surface.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: January 12, 1999
    Assignee: SurModics, Inc.
    Inventors: Lise W. Duran, Melvin J. Swanson, Richard A. Amos, Sheau-Ping J. Hu, Patrick E. Guire
  • Patent number: 5847213
    Abstract: There is provided a process for producing a tertiary amine compound in one step without using any subsidiary raw material or any solvent, by subjecting a secondary amine compound and an alcohol to an intermolecular dehydration reaction in a gas phase. The process uses, as a catalyst, an oxide containing an alkali metal element and/or an alkaline earth metal element and silicon.
    Type: Grant
    Filed: March 3, 1997
    Date of Patent: December 8, 1998
    Assignee: Nippon Shokubai Co., Ltd.
    Inventors: Akira Kurusu, Yuuji Shimasaki
  • Patent number: 5789491
    Abstract: Fluorinated imides useful for imparting repellency of low surface tension fluids to thermoplastic polymers of formulae ##STR1## wherein R.sub.1 is F(CF.sub.2).sub.x --(CH.sub.2).sub.m, or F(CF.sub.2).sub.x SO.sub.2 N(R.sub.5)(CH.sub.2)p wherein x is from about 4 to about 20, m is from about 2 to about 6, p is from 1 to about 12, and R.sub.5 is an alkyl radical of from 1 to about 4 carbons;R.sub.2 is a linear, branched or cyclic alkylene or poly(oxyalkylene) hydrocarbon group having from about 2 to about 15 carbons;R.sub.3 is selected from the group consisting of F(CF.sub.2).sub.x --(CH.sub.2).sub.m, F(CF.sub.2).sub.x --(CH.sub.2).sub.m --OC(O)--(CH.sub.2).sub.n, and F(CF.sub.2).sub.x SO.sub.2 N(R.sub.5)(CH.sub.2).sub.p OC(O)(CH.sub.2).sub.nwherein x is from about 4 to about 20, m is from about 2 to about 6, n is about 2 to about 12, p is from 1 to about 12, and R.sub.5 is an alkyl radical of from 1 to about 4 carbons;R.sub.4 is an alkyl or alkenyl group of from about 4 to about 20 carbons, andR.sub.
    Type: Grant
    Filed: June 19, 1997
    Date of Patent: August 4, 1998
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Theodor Arthur Liss, Kimberly Gheysen Raiford, Edward James Greenwood
  • Patent number: 5780645
    Abstract: A process for the alkylation of imides wherein the imides are reacted with a dialkyl carbonate, in the liquid state, at a temperature of between 100.degree. C. and 250.degree. C. and at a pressure of between 0 and 60 atmospheres in the presence of a basic catalyst. The dialkyl carbonate reagents are not very toxic and are thermally stable and their use as alkylation agents makes it possible to produce waste products with a negligible saline content.
    Type: Grant
    Filed: December 31, 1996
    Date of Patent: July 14, 1998
    Assignee: Enichem S.p.A.
    Inventors: Marcello Notari, Franco Mizia, Franco Rivetti
  • Patent number: 5773630
    Abstract: N-Substituted cyclic imides are obtained by reacting a cyclic acid anhydride with an amine in the presence of a solvent and an acid catalyst at 80.degree. to 200.degree. C. and with removal of the water formed, it being particularly advantageous to carry out this reaction in the presence of a stabilizer and an inert, dipolar aprotic cosolvent, optionally to add an inert organic solvent of low or zero polarity to the reaction mixture present after the reaction, to add a non-aqueous base in an amount of 0.5 to 50% by weight, based on the cyclic anhydride of the formula (II) used, and to separate off the precipitate formed to give a filtrate containing the N-substituted cyclic imide.
    Type: Grant
    Filed: February 6, 1996
    Date of Patent: June 30, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Torsten Groth, Karl-Erwin Piejko, Winfried Joentgen, Josef Kasbauer, Bernd Alig, Werner Struver
  • Patent number: 5756762
    Abstract: The present invention relates to a novel enantiospecific processes for preparing (S)-4-amino-hepta-5,6-dienoic acid and pharmaceutically acceptable salts thereof, which is useful as an irreversible inhibitor of GABA-T, to novel intermediates thereof, and a process for preparing an intermediate thereof.
    Type: Grant
    Filed: January 9, 1997
    Date of Patent: May 26, 1998
    Assignee: Merrell Pharmaceuticals Inc.
    Inventor: H. Michael Kolb
  • Patent number: 5750680
    Abstract: N-vinyllactam derivatives protected at the 3-position are provided and represented by the following formula (I). These are polymerized into homo- and copolymers for use in microlithography of semiconductor manufacture. The polymers are used as a photoresist material suitable for a deep UV process so that pictures of high sensitivity and high resolution can be obtained. In addition, ultrafine circuits can be formed and an exceptional improvement in pattern formation can be accomplished through the use of the photoresist of the invention.
    Type: Grant
    Filed: September 12, 1996
    Date of Patent: May 12, 1998
    Assignees: Hyundai Electronics Industries Co., Ltd., Korea Advanced Institute of Science & Technology
    Inventors: Jin Baek Kim, Min Ho Jung, Kyeong Ho Chang
  • Patent number: 5750725
    Abstract: The present invention provides a class of compounds having the formula:Y--R--CH.sub.2 --CH.sub.2 --?O--CH.sub.2 --CH.sub.2 !.sub.n --R'--Y'wherein n is an integer from about 5 to about 200; R is carbamate, urea, or amide; R' is carbamate, urea, amide, or oxygen; Y is 4-phenylmalemimido or 3-phenylmaleimido; and Y' is 4-phenylmalemimido, 3-phenylmaleimido, methyl or hydrogen. The present invention also provides various hemoglobin compositions modified with the class of compounds of the present invention, processes for preparing these compositions, as well as pharmaceutical compositions comprising these compositions.
    Type: Grant
    Filed: September 26, 1996
    Date of Patent: May 12, 1998
    Assignee: Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva
    Inventors: A. Seetharama Acharya, Belur N. Manjula, Paul K. Smith
  • Patent number: 5734063
    Abstract: The present invention provides a method for preparation of a compound of the formula (I) useful as a fog restrainer for a silver halide light-sensitive material, especially for a heat-developing light-sensitive material and a synthetic intermediate for the fog restrainer. The method makes it possible to obtain the fog restrainer in good yield and in short steps. ##STR1## wherein, R.sup.1 is alkyl, cycloalkyl, or aryl, R.sup.2 and R.sup.3 are hydrogen atom or alkyl, R.sup.4 is hydrogen atom or acyl, and R.sup.1 and R.sup.4 may be bonded together to form 5- or 6-membered ring.
    Type: Grant
    Filed: October 24, 1996
    Date of Patent: March 31, 1998
    Assignee: Fuji Photo Film Co.,Ltd.
    Inventors: Katsuyoshi Yamakawa, Tadahisa Sato
  • Patent number: 5710140
    Abstract: The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
    Type: Grant
    Filed: August 16, 1996
    Date of Patent: January 20, 1998
    Assignee: Merck Frosst Canada, Inc.
    Inventors: Yves Ducharme, Jacques Yves Gauthier, Petpiboon Prasit, Yves Leblanc, Zhaoyin Wang, Serge Leger, Michel Therien
  • Patent number: 5703104
    Abstract: Compounds, topical compositions and methods useful for preventing the penetration of toxic chemicals through the skin of a mammal are disclosed.The compounds of the invention provide an enhanced barrier for the skin of a mammal to further inhibit or decrease the passage of bioactive agents through the skin of a mammal either from the outside environment into the systems of said mammal or from the mammal into the outside environment.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: December 30, 1997
    Assignee: Durham Pharmaceuticals LLC
    Inventors: James V. Peck, Gevork Minaskanian, Mark C. Sleevi
  • Patent number: RE36607
    Abstract: This invention relates to benzolididene compounds of the formula ##STR1## in which R.sup.2 represents the radical ##STR2## in which R.sup.4 and R.sup.5 are identical or different and denote halogen, cyano, ethinyl, trifluoromethoxy, methylthio, nitro, trifluoromethyl or straight-chain or branched alkyl, alkenyl, alkinyl or alkoxy having up to 4 carbon atoms, and one of the substituents optionally represents hydrogen,or a salt thereof.[...]..Iadd., andA represents hydrogen or straight-chain or branched alkyl having up to 8 carbon atoms, or represents phenyl or benzyl which are optionally substituted one to three times by identical or different substituents from the series consisting of hydroxyl, nitro, halogen, cyano, carboxyl, trifluoromethyl, trifluoromethoxy, straight-chain or branched alkoxy having up to 6 carbon atoms or by a group of the formula --NR.sup.6 R.sup.7 or --SO.sub.2 R.sup.8, in whichR.sup.6 and R.sup.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: March 7, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Joachim Mittendorf, Peter Fey, Bodo Junge, Johannes Kaulen, Kai van Laak, Heinrich Meier, Rudolf Schohe-Loop